Cancer 2035: A Roadmap for the Future

Events

Feb 23, 2026

Cancer 2035: A Roadmap for the Future
Date: February 23–24, 2026
Location: Washington, DC
https://milkeninstitute.org/cancer-2035-roadmap-future

To download the presentation, please click the link below.
Download Presentation (PDF)

Contact us at

+1-844-MY NK CELLS (+1-844-696-5235)

Visit Newsroom

Solutions for Patients

ImmunityBio creates targeted, personalized immunotherapies that are designed to strengthen the immune system and enable it to outsmart your disease.

Opportunities for Trial Investigators

Next-generation adenovirus-vectored anti-cancer vaccines make appealing therapeutics for testing by trial investigators who want to make a contribution to clinical cancer research.

Tools for Research Scientists

Our NK-92® easy-to-maintain and highly cytotoxic natural killer cell line provides a versatile bioanalytical testing tool that can help researchers develop functional killing assays that are more consistent and reliable than donor blood and reporter gene assays.